Depository Interest Facility and CREST Admission

RNS Number : 5027I
AOI Medical, Inc.
19 November 2008

AOI Medical, Inc.

Depository Interest Facility and Admission to CREST

London, UK, 19 November 2008 - AOI Medical, Inc. (the "Company" or "AOI") (AIM: AOI), the medical device company focusing on innovative
orthopaedic medical devices for the spine and trauma markets, is pleased to announce that, with effect from 25 November 2008 (the "Effective
Date"), AOI shareholders will, after certifying as to certain representations as to U.S. securities laws, be able to hold and transfer AOI's
common shares ("Common Shares") electronically within the CREST system as depository interests. This is intended to enhance the liquidity in
the trading of the Common Shares and allow investors, who may have previously had difficulty in dealing, to deal more easily.

The Company, through its registrar, Computershare Investor Services (Channel Islands) Limited (the "Registrar"), has established a
depository interest facility to enable qualifying shares ("Qualifying Shares") to be traded in electronic form within the CREST system under
a new ISIN number. From the Effective Date, qualifying Common Shares ("Qualifying Shares") will be eligible to be transferred to the new
ISIN number. These Qualifying Shares may then be admitted to CREST as Depository Interests ("DIs"), thereby allowing settlement of
transactions in Qualifying Shares within the CREST system. Holders of DIs have the same rights as holders of Common Shares in the Company.

CREST is an electronic paperless share transfer and settlement system that allows shares and other securities (including DIs) to be held
in electronic rather than paper form.

The transferred Qualifying Shares will be represented in CREST by the new ISIN number US0018361057. Common shares of the Company which
are not Qualifying Shares will continue to be represented by ISIN number USU002711039.

Common Shares will be eligible for settlement through CREST where they were issued or not held by an affiliate of the Company within the
last 12 months, whether or not in an offering conducted outside the United States pursuant to Regulation S of the United States Securities
Act of 1933, as amended (the "US Securities Act") and where the shareholder is not an affiliate of the Company and has not been an affiliate
for the prior three months.

Shareholders should note that in order to hold Qualifying Shares (if they are eligible to do so), they will need to provide their share
certificates to the Registrar and make certain representations to the Company to have any restrictive legend removed. Shareholders should
then contact their broker or custodian to arrange to have their unrestricted shares dematerialised and transferred into the CREST system.
Explanatory letters have been sent to all shareholders, except those that are known to the Company to be affiliates. A copy of this letter
is available from the Company's website, www.aoimedical.net.

Shareholders should contact the Registrar on +44 (0)1534 825200 if they require further confirmation of whether their shares are
Qualifying Shares and the process for dematerialisation of their Qualifying Shares or for receiving new share certificates.

Shareholders who do not wish to deposit their Common Shares into CREST may continue to hold them in certificated form. Further, if a
shareholder subsequently wishes to remove shares from the CREST system, certificates representing the Common Shares will be reissued.

For further details please contact:

AOI Medical, Inc. Tel: +1 407 770 1800
William J. Christy, CEO
Angela Johnston, CFO

Financial Dynamics Tel: +44 (0) 20 7831 3113
Ben Atwell
Susan Quigley

Numis Securities Limited Tel: +44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Brent Nabbs
Corporate Broking: David Poutney

Background to AOI Medical, Inc.

AOI is a medical device company focussing on the development and commercialisation of innovative orthopaedic medical devices for the
spine and trauma markets. It is progressing the development of three separate technology platforms: Ascendx* VCF Reduction System, BAMF
Trauma and Cervical Plate. Further information can be found at www.aoimedical.net

This information is provided by RNS
The company news service from the London Stock Exchange

END

MSCZKLFFVFBLFBF

Aoi (Regs) (LSE:AOI)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024